comparemela.com

Latest Breaking News On - Blue venture fund - Page 4 : comparemela.com

Sempre Health Secures $20 Million in Funding From Cencora Ventures, Echo Health Ventures, and Others

/PRNewswire/ Sempre Health, the leading solution for behavior-based healthcare pricing, today announced $20M in additional funding from three new investors,.

United statesJose guerolaAnurati mathurMichele foxLeslie donatoBlue venture fundCencora incEcho health venturesSempre healthAb health venturesPrincipal at echo health venturesCencora venturesEcho healthIndustry venturesNet promoterChief strategy officer

Sempre Health Raises $20M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San franciscoUnited statesAnurati mathurEcho health venturesSempre healthBlue venture fundCencora venturesEcho health

Sempre Health Nabs $20M for Behavior-Based Healthcare Pricing

Sempre Health, a San Francisco-based solution for behavior-based healthcare pricing raises $20M in additional funding from 3 new investors

San franciscoUnited statesBlue venture fundEcho health venturesSempre healthWhat you should knowCencora venturesEcho healthIndustry ventures

Sequoia fund cutbacks underscore new realities of venture capital market

Earlier this year, the venture capital firm told its portfolio companies to buckle down. Now it’s doing the same.

City ofUnited kingdomUnited statesJackson fordyceCyril demariaJessica mathewsMike moritzBlue venture fundCover massReata pharmaceuticalsWall street journalreportedAsset allocationInsight partnersTerm sheetMenlo parkHikma ventures

Octave Bioscience Closes $30M Extension to Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

William hagstromHikma pharmaceuticalsEcho health venturesMerck global health innovation fundBlue venture fundOctave biosciencesMenlo parkHikma pharmaceuticalsHikma venturesIntermountain venturesNorthpond venturesDeerfield managementCasdin capitalMerck global health innovationFounder william hagstromOctave bioscience

vimarsana © 2020. All Rights Reserved.